Friday, November 10, 2023

Finning International Inc

Sound bite for Twitter and StockTwits is: Dividend Growth Industrial. Results of stock price testing is that the stock price is probably reasonable. Results of stock price testing is that the stock price is probably reasonable. Debt Ratios are probably fine but could improve. The Dividend Payout Ratios (DPR) are fine except for FCF. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Finning International Inc.

Is it a good company at a reasonable price? I like a total return of 8%, dividends and capital gains. Mostly this company has not produced this. However, there are a lot of analysts that feel that the company is going to better in the future. Growth over the past 12 months has been good in some cases. See charts below. However, I am still glad I bought Toromont rather than this stock. Results of stock price testing is that the stock price is probably reasonable.

The Growth for the last 12 months up to the end of September 2023.

Item Value Growth
Revenue Growth $9,452 15.06%
AEPS Growth $3.85 18.46%
Net Income Growth $574 14.12%
Cash Flow Growth $347 34600.00%
Dividend Growth $0.99 5.68%
Stock Price Growth $35.37 5.08%

The growth over the past 5 years is better than that over the past 10 years.

Year Item Tot. Growth Per Year
5 Revenue Growth 31.13% 5.57%
5 AEPS Growth 138.97% 19.03%
5 Net Income Growth 127.60% 17.88%
5 Cash Flow Growth -99.65% N/C
5 Dividend Growth 25.23% 4.60%
5 Stock Price Growth 6.12% 1.19%
10 Revenue Growth 24.05% 2.18%
10 AEPS Growth 65.82% 5.19%
10 Net Income Growth 48.98% 4.07%
10 Cash Flow Growth -99.25% N/C
10 Dividend Growth 69.64% 5.43%
10 Stock Price Growth 37.00% 3.20%

I do not own this stock of Finning International Inc (TSX-FTT, OTC-FINGF). When I was in the market to buy an industrial stock in this area in 2007, I look at this stock was well as Toromont Industries (TSX-TIH). At the time I liked Toromont better, so that is what I bought.

When I was updating my spreadsheet, I noticed that I still liked Toromont better than this stock. I will do a blog entry later about this.

If you had invested in this company in December 2012, for $1,007.34 you would have bought 41 shares at $24.57 per share. In December 2022, after 10 years you would have received $315.42 in dividends. The stock would be worth $1,380.06. Your total return would have been $1,695.78. This is a total return would be a total return of 5.90% per year with 3.20% from capital gain and 2.70% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$24.57 $1,007.37 41 10 $315.72 $1,380.06 $1,695.78

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 2.83%. The 5 and 10 year median dividend yield is 2.82% and 2.79%. The historical median dividend yield is low (below 2%) at 1.98%. The dividend growth is low (below 8%) at 4.6% per year over the past 5 years. The last dividend increase was in 2023 and it was for 5.9%.

The Dividend Payout Ratios (DPR) are fine except for FCF. The DPR for 2022 for Earnings per Share (EPS) is 29% with 5 year coverage at 43%. The DPR for 2022 for Adjusted Earnings per Share (AEPS) is 29% with 5 year coverage at 48%. The DPR for 2022 for Cash Flow per Share (CFPS) is 12% with 5 year coverage at 18%. The DPR for 2022 for Free Cash Flow (FCF) is negative with 5 year coverage at 71%.

Item Cur 5 Years
EPS 28.71% 43.08%
AEPS 28.71% 47.47%
CFPS 12.24% 17.89%
FCF -82.01% 70.98%

Debt Ratios are probably fine but could improve. The Long Term Debt/Market Cap Ratio for 2022 is good at 0.16. The Liquidity Ratio for 2022 is a bit low at 1.41 and 1.41 currently. If you add in Cash Flow after dividends does not help much. The Debt Ratio for 2022 is fine at 1.51 and 1.49 currently. The Leverage and Debt/Equity Ratios for 2022 are fine at 2.98 and 1.97. However, the current ratios are too high at 3.07 and 2.07. I prefer them to be below 3.00 and 2.00.

Type Year End Ratio Curr
Lg Term R 0.16 0.16
Intang/GW 0.13 0.11
Liquidity 1.41 1.41
Liq. + CF 1.36 1.46
Debt Ratio 1.51 1.49
Leverage 2.98 3.07
D/E Ratio 1.97 2.07

The Total Return per year is shown below for years of 5 to 34 to the end of 2022. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 4.60% 3.79% 1.19% 2.59%
2012 10 5.43% 5.90% 3.20% 2.70%
2007 15 6.55% 3.20% 1.08% 2.12%
2002 20 11.81% 7.48% 4.96% 2.52%
1997 25 9.34% 7.68% 5.42% 2.26%
1992 30 11.07% 11.25% 8.32% 2.93%
1987 34 8.16% 10.90% 8.04% 2.87%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 11.87, 14.38 and 17.82. The corresponding 10 year ratios are 12.26, 14.96 and 18.12. The corresponding historical ratios are 12.28, 15.85 and 19.58. The current P/E Ratio is 9.02 based on a stock price of $35.37 and EPS estimate for 2023 of $3.92. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 12.25, 17.23 and 17.44. The corresponding 10 year ratios are 13.14, 17.09 and 19.11. The current P/AEPS Ratio is 9.12 based on a stock price of $35.37 and AEPS estimate for 2023 of $3.88. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I get a Graham Price of $38.16. The 10-year low, median, and high median Price/Graham Price Ratios are 1.01, 1.23 and 1.45. The current P/GP Ratio is 0.93 based on a stock price of $35.37. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Book Value per Share Ratio of 2.21. The current P/B Ratio is 2.12 based on a Book Value of $2,519M, Book Value per Share of $16.68 and a stock price of $35.37. The current ratio is 4% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 10.86. The current P/CF Ratio is 16.84 based on Cash Flow per Share estimate for 2023 of $2.10, Cash Flow of $317M and a stock price of $35.37. The current ratio is 55% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 1.98%. The current dividend yield is 2.83% based on dividends of $1.00 and a stock price of $35.37. The current dividend yield is 41% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.79%. The current dividend yield is 2.83% based on dividends of $1.00 and a stock price of $35.37. The current dividend yield is 1.4% above the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable and below the median.

The 10-year median Price/Sales (Revenue) Ratio is 0.65. the current P/S Ratio is 0.55 based on a stock price of $35.37, Revenue estimate for 2023 of $9,659M and Revenue per Share of $63.95. The current ratio is 15% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably reasonable. The 10 year dividend yield test says this and it is confirmed by the P/S Ratio test. Most of the other testing is saying the stock price is cheap except for the P/CF test that says the price is expensive.

When I look at analysts’ recommendations, I find Strong Buy (3), Buy (4) and Hold (2). The consensus would be a Strong Buy. The 12 months stock price consensus is $48.67 with a high at $54.00 and a low of $40.00. The consensus price implies a total return of 40.43% with 37.60% from capital gains and 2.83% from dividends.

Analysts earlier this year on Stock Chase said the stock was a buy, but the most recent recommendation is a Partial Sell. Stock Chase gives this stock 4 stars out of 5. It is on all the dividend lists that I follow. Ambrose O'Callaghan on Motley Fool really likes this stock and give 5 things you should know about it. Christopher Liew on Motley Fool thinks this stock will do well with rising interest rates. The company put out a Press Release on their 2022 year-end result. The company put out a Press Release on their third quarter results for 2023.

Simply Wall Street on Yahoo Finance thinks that this company has been doing well. Simply Wall Street gives this stock 4 stars out of 5. They list 3 warnings of debt is not well covered by operating cash flow; dividend of 2.83% is not well covered by cash flows; and significant insider selling over the past 3 months.

Finning International Inc is a dealer and distributor of heavy-duty machinery and parts of the Caterpillar brand. The company sells and rents Caterpillar machinery to the mining, construction, petroleum, forestry, and power system application industries. The company operates in Canada, South America, UK and Ireland, and others. Its web site is here Finning International Inc.

The last stock I wrote about was about was Crescent Point Energy Corp (TSX-CPG, NYSE-CPG) ... learn more. The next stock I will write about will be Quarterhill Inc (TSX-QTRH, OTC-QTRHF) ... learn more on Monday, November 13, 2023 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, November 8, 2023

Crescent Point Energy Corp

Sound bite for Twitter and StockTwits is: Dividend Paying Resource. Debt Ratios are fine. Results of stock price testing is that the stock price is reasonable and may even be cheap. The Dividend Payout Ratios (DPR) are currently fine. The current dividend yield is moderate with dividends growth restarting. See my spreadsheet on Crescent Point Energy Corp.

Is it a good company at a reasonable price? This is a resource stock and I always view them as short term buys. Although the stock price is mostly showing as reasonable, the stock is down a lot this month. Resource stocks are always risky. However, it is a good sign when a company raises the dividend as this company has done recently. I am generally not a trader, so this really does not appeal to me. However, going by the current dividend testing, the stock price looks cheap.

I do not own this stock of Crescent Point Energy Corp (TSX-CPG, NYSE-CPG). I got this idea to look into this stock from another blogger, My Own Advisor and his November 2012 blog entry on great Canadian dividend paying stocks. I also noticed that several people at the Toronto Money Show of 2013 mentioned this stock.

When I was updating my spreadsheet, I noticed that 6 times in the last 10 years this company had earnings losses. Then in 2021 they had EPS of $4.11 and in 2022, they had earnings of $2.60. Earnings are expected to be lower over the next 3 years at $1.74, $1.74, and $1.45 given after the second quarter and then changed to $0.77, $1.63, $2.01 after the third quarter.

If you had invested in this company in December 2012, for $1,015.74 you would have bought 27 shares at $37.62 per share. In December 2022, after 10 years you would have received $253.19 in dividends. The stock would be worth $260.82. Your total return would have been $514.01. This is a total return would be a total loss of 9.20% per year with 12.71% from capital loss and 3.51% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$37.62 $1,015.74 27 10 $253.19 $260.82 $514.01

The current dividend yield is moderate with dividends growth restarting. The current dividend yield is moderate (2% to 4% ranges) at 4.17%. The 5 year dividend yield is low (below 2%) at 0.84%. The 10 year median dividend yield is moderate at 2.95%. The historical median dividend yield is high (7% and above) at 7.09%. Dividends were flat from 2010 to 2014 and then dividends were decreasing until 2021 and then they were increases in 2022 by 2833% year over year and in 2023 73% year over year.

This company was an income trust and it converted back to a corporation in 2009. These types of companies do have a tough time getting their dividend payments to the right level. The problem being that Income Trust companies and pay very high dividends and corporations cannot.

The Dividend Payout Ratios (DPR) are currently fine. The DPR for 2022 for Earnings per Share (EPS) is 10% with 5 year coverage not calculable because of earnings losses. The DPR for 2022 for Adjusted Earnings per Share (AEPS) is 15% with 5 year coverage at 23%. The DPR for 2022 for Adjusted Funds from Operations (AFFO) is 6% with 5 year coverage at 5%. The DPR for 2022 for Cash Flow per Share (CFPS) is 6% with 5 year coverage at 5%. The DPR for 2022 for Free Cash Flow (FCF) is 17% with 5 year coverage at 19%.

Item Cur 5 Years
EPS 9.81% N/C
AEPS 15.09% 22.57%
AFFO 5.63% 4.69%
CFPS 6.36% 4.71%
FCF 17.22% 19.03%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2022 is good at 0.29 and currently at 0.48. The Liquidity Ratio for 2022 is low at 0.80 and 1.29 currently. If you add in Cash Flow after dividends, the result is a ratio of 2.45 and currently a ratio of 2.98, which are fine. The Debt Ratio for 2022 is good at 3.17 and currently at 2.23. The Leverage and Debt/Equity Ratios for 2022 are fine at 1.46 and 0.46 and are currently good at 1.82 and 0.82.

Type Year End Ratio Curr
Lg Term R 0.29 0.48
Intang/GW 0.04 0.04
Liquidity 0.80 1.29
Liq. + CF 2.45 2.98
Liq. CF. DB 4.34 4.28
Debt Ratio 3.17 2.23
Leverage 1.46 1.82
D/E Ratio 0.46 0.82

The Total Return per year is shown below for years of 5 to 21 to the end of 2022. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 -9.38% 1.61% 0.17% 1.44%
2012 10 -22.35% -9.20% -12.71% 3.51%
2007 15 -14.73% 3.78% -6.09% 9.88%
2002 20 -5.77% 18.30% -0.52% 18.82%
2001 21 37.55% 4.85% 32.70%

The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and useless. The corresponding 10 year ratios are negative and useless. The corresponding historical ratios are 2.83, 5.09, and 7.35. These are low because of all the years of earnings losses. The current P/E Ratio is 12.45 based on a stock price of $9.59 and EPS estimate for 2023 of $0.77. A ratio of 12.45 is a reasonable one.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 4.26, 6.71 and 8.83. The corresponding 10 year ratios are 12.95, 15.98 and 23.00. The current P/AEPS Ratio is 7.10 based on a stock price of $9.59 and 2023 AEPS estimate of $1.35. The current ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Funds from Operations (AFFO) data. The 5-year low, median, and high median Price/ Adjusted Funds from Operations Ratios are 1.18, 2.17 and 3.44. The corresponding 10 year ratios are 2.23, 2.90 and 3.73. The current P/AFFO Ratio is 2.29 based on a stock price of $9.59 and AFFO estimate for 2023 of $4.18. This ratio is between the low and median ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $17.74. The 10-year low, median, and high median Price/Graham Price Ratios are 0.53, 0.71 and 1.04. The current P/GP Ratio is 0.54 based on a stock price of $9.59. This ratio is between the low and median ratios of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Book Value per Share Ratio of 0.79. The current P/B Ratio is 0.93 based on a Book Value of $5,710M, Book Value per Share of $10.37 and a stock price of $9.59. The current ratio is 17% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median. Any P/B Ratio below 1.50 is considered generally low.

I get a 10-year median Price/Cash Flow per Share Ratio of 2.94. The current P/CF Ratio is 2.25 based on Cash Flow per Share estimate for 2023 of $4.27, Cash Flow of $2,352M and a stock price of $9.59. The current ratio is 24% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 7.09%. The current dividend yield is 4.17% based on dividends of $0.38 and a stock price of $9.59. The current dividend yield is 41% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. The historical median dividend yield is high because this company used to be an income trust.

I get a 10 year median dividend yield of 2.95%. The current dividend yield is 4.17% based on dividends of $0.38 and a stock price of $9.59. The current dividend yield is 41% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 1.59. The current P/S Ratio is 1.33 based on Revenue estimate for 2023 of $3,958M, Revenue per Share of $7.18 and a stock price of $9.59. The current ratio is 16% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is reasonable and may even be cheap. The dividend yield test we should look at here is the 10 year one because this company used to be an income trust which could have very high dividend yields. This test says the stock price is cheap. The P/S Ratio test says it is reasonable and below the median. The rest of the testing is saying the stock price is either reasonable or cheap.

When I look at analysts’ recommendations, I find Strong Buy (4), Buy (5). The consensus would be a Strong Buy. The 12 month stock price consensus is $14.11 with a high of $16.00 and low of $13.00. The consensus price implies a total return of 20.33% with 16.16% from capital gains and 4.17% from dividends. This is not a particularly high price considering the recommends is a Strong Buy.

Stock Chase. Stock Chase gives this stock 5 stars out of 5. It is not on any of the dividend lists I follow. Puja Tayal on Motley Fool thinks this is not the time to buy this stock. Jitendra Parashar on Motley Fool thinks you should buy and hold this stock for the long term. The company put out a Press Release about their 2022 results. The company put out a press release on Newswire about this third quarter of 2023 results.

Simply Wall Street via Yahoo Finance talks about this company buying Hammerhead and raising dividends. Simply Wall Street gives this stock 2 and one half stars out of 5. It gives 3 warnings of has a high level of debt; unstable dividend track record; and profit margins (7.1%) are lower than last year (52.6%).

Crescent Point Energy Corp is an independent exploration and production company. It is engaged in acquiring, developing, and holding interests in petroleum and natural gas properties and assets related thereto through a general partnership and wholly-owned subsidiaries. Its web site is here Crescent Point Energy Corp.

The last stock I wrote about was about was Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more. The next stock I will write about will be Finning International Inc (TSX-FTT, OTC-FINGF) ... learn more on Friday, November 10, 2023 around 5 pm. Tomorrow on my other blog I will write about Dividend Investing.... learn more on Thursday, November 09, 2023 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, November 6, 2023

Innergex Renewable Energy

Sound bite for Twitter and StockTwits is: Dividend Paying Utility. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are awful. The Dividend Payout Ratios (DPR) can be covered by Cash Flow, but not earnings. The current dividend yield is high with dividend growth stopping. See my spreadsheet on Innergex Renewable Energy.

Is it a good company at a reasonable price? Personally, I like to buy companies that can produce earnings. This company seems to have a problem with that. Some people like to buy companies with high dividend yields and wait for the companies to recover. There is, of course, a risk to that. Companies can reduce the dividend payments, or worse go bankrupt. No one seems to think this will happen to this company. I am not generally interested in this sort of investing. It can sometimes be profitable on a short term basis. The stock price seems to be cheap.

I do not own this stock of Innergex Renewable Energy (TSX-INE, OTC-INGXF). In 2006 I bought Innergex Power on a buy rating and favorable report from TD although it has only been going from 2003. In 2008 I sold Innergex as I did not think that it is a stock I want to hold as dividend increased less than the rate of inflation.

When I was updating my spreadsheet, I noticed that this company does have a hard time earning a profit. In the last 10 years, there have been earning losses in 6 years and profit in 4 years. Even with the Adjusted Earnings per Share, there were losses in 3 years and profits in 7 years over the past 10 years. Also, the debt ratios are awful.

The current dividend yield is high with dividend growth stopping. The current dividend yield is high (7% and above) at 7.35%. The 5 and 10 year median dividend yields are moderate (2% to 4% ranges) at 4.14%, and 4.76%. The historical median dividend yield is good (5% to 5% ranges) at 5.74%. The dividend growth is low (below 8%) at 1.9% per year over the past 5 years. The last dividend increase was in 2020 and it was for 2.9%. Dividend have been flat since then and they are not expected to raise within the next 3 years.

The Dividend Payout Ratios (DPR) can be covered by Cash Flow, but not earnings. The DPR for 2022 for Earnings per Share (EPS) cannot be calculated. This is because of an earnings loss. The DPR for 5 year coverage cannot be calculated because earning losses are higher than the dividends. The DPR for 2022 for Adjusted Earnings per Share (AEPS) cannot be calculated because of an earnings loss, but with 5 year coverage at 173%. This means that the dividends cannot be covered by AEPS as AEPS is lower than dividends paid. You certainly want a value under 100% and better still under 75%. The DPR for 2022 for Cash Flow per Share (CFPS) is 22% with 5 year coverage at 31%. These are fine. The DPR for 2022 for Free Cash Flow (FCF) is 48% with 5 year coverage at 980%. Sites do not agree on what the FCF is.

Item Cur 5 Years
EPS N/C N/C
AEPS N/C 173.43%
CFPS 22.40% 31.38%
FCF 47.96% 979.84%

Debt Ratios are awful. The Long Term Debt/Market Cap Ratio for 2022 is far too high in 2022 at 1.66 and currently at 2.91. This means that the long term debt is higher than the market value of this stock. It is a bad situation. The Liquidity Ratio for 2022 is too log at 0.81 and currently at 0.99. Currently if you add in cash Flow after dividends it is 1.25. This is low for safety’s sake. I prefer it to be at 1.50 or higher. The Debt Ratio for 2022 is too low at 1.21 and currently at 1.19. I prefer it to be at 1.50 or higher. The Leverage and Debt/Equity Ratios for 2022 are far too high at 5.79 and 4.79 and even worse currently.

Type Year End Ratio Curr
Lg Term R 1.66 2.91
Intang/GW 0.43 0.77
Liquidity 0.81 0.99
Liq. + CF 0.63 1.25
Liq. CF DB 2.29 1.91
Debt Ratio 1.21 1.19
Leverage 5.79 6.39
D/E Ratio 4.79 5.39

The Total Return per year is shown below for years of 5 to 19 to the end of 2022. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 1.91% 7.06% 2.38% 4.67%
2012 10 2.19% 9.83% 4.58% 5.25%
2007 15 0.36% 10.71% 4.69% 6.02%
2003 19 0.75% 9.68% 3.60% 6.09%

The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and therefore useless. The corresponding 10 year ratios are also negative and useless. The corresponding historical ratios are also negative and useless. The current P/E Ratio is 48.95 based on a stock price of $9.79 and EPS estimate for 2023 of $0.20. This is a very high ratio. Ratios are negative or high because of earnings losses or very low earnings.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are negative and therefore useless. The corresponding 10 year ratios are 46.40, 54.12 and 61.85. The current P/AEPS Ratio is 32.63 based on a stock price of $9.79 and AEPS estimate for 2023 of $0.30. By this measure, this stock price testing suggests that the stock price is relatively cheap. However, the ratios are very high because of very low earnings.

I get a Graham Price of $6.15. The 10-year low, median, and high median Price/Graham Price Ratios are 3.12, 3.47 and 3.86. The current P/GP Ratio is 1.59 based on a stock price of $9.79. The current ratio is below the low ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap. These ratios are very high due to very low earnings. Normally a P/GP Ratio is 1.20 is considered high.

I get a 10-year median Price/Book Value per Share Ratio of 3.75. The current P/B Ratio is 1.75 based on a Book Value of $1,139M, Book Value per Share of $5.60 and a stock price of $9.79. The current ratio is 53% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have Book Value per Share estimate for 2023 of $4.96. This implies a Book Value of $1,010M, and P/B Ratio of 1.97 with a stock price of $9.79. The analyst calculated the book value differently than I do and their 10 year median ratio is 2.86. The ratio of 1.97 is 31% below the 10 year ratio of 2.86. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Cash Flow per Share Ratio of 10.52. The current P/CF Ratio is 6.94 based on Cash Flow per Share estimate for 2023 of $1.41, Cash Flow of $287M and a stock price of $9.79. The current ratio is 34% below the 10 year ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 5.74%. The current dividend yield is 7.35% based on a stock price of $9.79 and dividends of $0.72. The current dividend yield is 28% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 4.76%. The current dividend yield is 7.35% based on a stock price of $9.79 and dividends of $0.72. The current dividend yield is 55% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 4.53. The current P/S Ratio is 2.00 based on Revenue estimate for 2023 of $996M, Revenue per Share of $4.89 and a stock price of $9.79. The current ratio is 58% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably cheap. After all, the stock price is down by 40% year to date. It is down by 64% from its high of $27.37 in 2020. Both the dividend yield tests and the P/S Ratio test says that the stock price is cheap. All the testing is pointing to a cheap price, although this stock has very high ratios due especially to the lack of earnings.

When I look at analysts’ recommendations, I find Buy (6), Hold (2) and Sell (1). The consensus would be a Buy. The 12 months stock price consensus is $14.89 with a high of $20.00 and low of $10.00. The price consensus of $14.89 implies a total return of $59.45% with 52.09% from capital gains and 7.35% from dividends.

The only comments on Stock Chase in 2023 says it is highly leveraged and they would like to see profitability before recommending this stock. This stock is on the Maple Money list and the Dividend Aristocrat lists, but not on the Money Sense dividend list. Stock Chase gives this stock 1 star out of 5. Aditya Raghunath on Motley Fool wonders if the dividends are sustainable. Demetris Afxentiou on Motley Fool likes this stock because it is into green energy. The company put out a press release on Newswire about their results for 2022. The company put out a press release on Newswire about their second quarter results of 2023.

Simply Wall Street via Yahoo Finance put out a report on this company. They have one warning out on this stock of dividend of 7.4% is not well covered by earnings or cash flows. Simply Wall Street gives this stock 3 and one half stars out of 5. I am surprised that they have no warning out on this company’s debt.

Innergex Renewable Energy Inc is an independent Canadian renewable power producer. It develops, acquires, owns, and operates hydroelectric, wind, and solar facilities in Canada, the United States, France, and Chile. Its web site is here Innergex Renewable Energy.

The last stock I wrote about was about was Johnson and Johnson (NYSE-JNJ) ... learn more. The next stock I will write about will be Crescent Point Energy Corp (TSX-CPG, NYSE-CPG) ... learn more on Wednesday, November 8, 2023 around 5 pm. Tomorrow on my other blog I will write about Frances Horodelski.... learn more on Tuesday, November 07, 2023 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Also, on my book blog I have put a review of the book The Whisper on the Night Wind by Adam Shoalts learn more...

Saturday, November 4, 2023

Johnson and Johnson

Sorry, but I am publishing this on Saturday morning as I simply ran out of time to do so on Friday as I had somewhere else to be.

Sound bite for Twitter and StockTwits is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably reasonable. Debt Ratios currently are an improvement over those of 2022 for Liquidity and rest are fine. Some Dividend Payout Ratios (DPR) are fine, but the Cash Flow per Share ratios are too high. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Johnson and Johnson.

Is it a good company at a reasonable price? There seems to be a lot of disagreements on whether this is a good stock to buy and hold currently. If you do buy it as a Canadian, I would use a US$ account. Then you do not have to deal with currency exchange. Currently, I do not hold any US stocks and I have no intensions of buying any in the near future. According to my testing the stock price seems reasonable.

I do not own this stock of Johnson and Johnson (NYSE-JNJ). As Canadians, we are told we should be buying US stocks for our portfolio. It is often recommended that we have at least 25% of our portfolio in US stocks. I have never followed this, although I have tried dipping into the US market, but I have never made any money there. I bought some of this stock in June 2005 and realized a year later, in June of 2006 that it was going nowhere for me and sold. I lost almost 17% of my investment. When I bought in 2005, all the analysts were saying that it was a good buy at that time.

When I was updating my spreadsheet, I noticed I did look at 5 year total returns from 199 to 2022. For the years 2003 to 2012, this stock underperformed. I think that this sort of stock should produce a total return of 8% per year, part from capital gain and part from dividends. See chart below.

Date Tot. Ret Beg Yield Beg P/S Beg P/E
12/31/99 21.28% 2.06% 2.24 17.55
12/31/00 21.28% 1.50% 2.94 22.98
12/31/01 20.38% 1.45% 3.11 23.82
12/31/02 11.93% 1.31% 3.85 27.72
12/31/03 5.42% 1.16% 4.70 39.54
12/31/04 7.89% 1.17% 4.56 31.72
12/31/05 4.44% 1.18% 5.05 32.63
12/31/06 3.75% 1.17% 5.56 32.53
12/31/07 6.82% 1.50% 4.35 24.59
12/31/08 6.05% 1.83% 3.59 21.09
12/31/09 2.83% 1.73% 3.98 22.33
12/31/10 3.52% 2.12% 3.71 17.37
12/31/11 2.79% 2.20% 3.59 17.71
12/31/12 4.07% 2.43% 3.12 18.37
12/31/13 12.04% 3.00% 2.61 13.10
12/31/14 13.27% 3.00% 2.87 14.64
12/31/15 14.06% 3.41% 2.75 12.96
12/31/16 15.30% 3.43% 2.75 18.79
12/31/17 18.01% 3.42% 2.90 18.16
12/31/18 10.08% 2.83% 3.62 19.04
12/31/19 9.67% 2.64% 3.92 18.35
12/31/20 11.82% 2.87% 4.04 18.74
12/31/21 11.01% 2.73% 4.34 19.43
12/31/22 7.39% 2.38% 4.90 297.28
Current 3.20% 6.69 22.09

If you had invested in this company in December 2012, for $1,051.50 you would have bought 15 shares at $70.10 per share. In December 2022, after 10 years you would have received $520.20 in dividends. The stock would be worth $2,649.75. Your total return would have been $3,169.95. This is a total return would be a total gain of 12.94% per year with 9.68% from capital gain and 3.26% from dividends. This is all in US$.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$70.10 $1,051.50 15 10 $520.20 $2,649.75 $3,169.95

The current dividend yield is moderate with dividend growth low. The current yield is moderate (2% to 4% ranges) at 3.15%. The 5, 10 and historical dividend yields are also moderate at 2.65%, 2.79% and 2.44%. The dividends have grown at a low rate (below 8% per year) at 6.03% per year over the past 5 years. The last dividend increase was in 2023 and it was for 5.3%.

Some Dividend Payout Ratios (DPR) are fine, but the Cash Flow per Share ratios are too high. The DPR for 2022 for Earnings per Share (EPS) is 66% with 5 year coverage at 64%. The DPR for 2022 for Adjusted Earnings per Share (AEPS) is 44% with 5 year coverage at 45%. The DPR for 2022 for Cash Flow per Share (CFPS) is 67% with 5 year coverage at 49%. These are too high and I prefer them to be 40% or lower. The DPR for 2022 for Free Cash Flow (FCF) is 68% with 5 year coverage at 55%.

Item Cur 5 Years
EPS 66.12% 63.63%
AEPS 43.84% 44.53%
CFPS 67.33% 48.79%
FCF 67.98% 55.04%

Debt Ratios currently are an improvement over those of 2022 for Liquidity and rest are fine. The Long Term Debt/Market Cap Ratio for 2022 is good at 0.05. The Liquidity Ratio for 2022 is low at 0.99 and 1.12 currently. If you add in Cash Flow after dividends currently, the result is a ratio of 1.51, which is fine. The Debt Ratio for 2022 is good at 1.69. The Leverage and Debt/Equity Ratios for 2022 are fine at 2.44 and 1.44 and are currently good at 2.51 and 1.51.

Type Year End Ratio Curr
Lg Term R 0.05 0.06
Intang/GW 0.12 0.16
Liquidity 0.99 1.12
Liq. + CF 1.07 1.51
Debt Ratio 1.69 1.66
Leverage 2.44 2.51
D/E Ratio 1.44 1.51

The Total Return per year is shown below for years of 5 to 34 to the end of 2022 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below. This if held in an CDN$ account, which I would never suggest.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 7.67% 8.98% 9.06% 2.63%
2012 10 9.68% 5.38% 16.77% 3.67%
2007 15 9.24% 11.87% 8.98% 2.90%
2002 20 8.16% 7.40% 5.38% 2.02%
1997 25 10.47% 8.99% 6.79% 2.19%
1992 30 9.62% 10.78% 8.32% 2.45%
1988 34 11.73% 15.18% 11.36% 3.81%

The Total Return per year is shown below for years of 5 to 34 to the end of 2022 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 6.03% 7.39% 4.80% 2.59%
2012 10 6.37% 12.94% 9.68% 3.26%
2007 15 6.97% 9.47% 6.71% 2.76%
2002 20 8.99% 8.68% 6.19% 2.49%
1997 25 9.85% 9.46% 7.01% 2.45%
1992 30 10.50% 12.16% 9.19% 2.96%
1988 34 11.21% 14.49% 10.85% 3.64%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 21.28, 24.17 and 26.35. The corresponding 10 year ratios are 19.88, 22.55 and 24.50. The corresponding historical ratios are 16.56, 19.62 and 22.62. The current P/E Ratio is 22.45 based on a stock price of $151.29 and EPS estimate for 2023 of $6.73. The current P/E Ratio is between the low and median ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 14.60, 16.72 and 18.31. The corresponding 10 year ratios are 14.54, 16.35 and 18.19. The current P/AEPS Ratio is 14.99 based on a stock price of $151.29 and AEPS estimate for 2023 of $10.09. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $55.08. The 10-year low, median, and high median Price/Graham Price Ratios are 2.11, 2.41 and 2.64. The current P/GP Ratio is 2.75 based on a stock price of $151.29. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Book Value per Share Ratio of 5.64. The current ratio is 5.14 based on a stock price of $151.29, Book Value of $76,409M and Book Value per Share of $29.41. The current ratio is 8.8% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median. Note that the P/B Ratios are very high. This means that the breakup value of the company is far lower than the stock price. This also tells you that the stock price is expensive.

I also have Book Value per Share estimate for 2023 of $30.70. This implies a Book Value of $79,763 and a P/B Ratio of 4.93 for a stock price of $151.29. This ratio is 13% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 7.17. The current P/CF Ratio is 14.83 based on a stock price of $151.29, Cash Flow per Share estimate for 2023 of $10.20 and a Cash Flow of $26,501M. The current ratio is 107% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get an historical median dividend yield of 2.44%. The current dividend yield is 3.15% based on a stock price of $151.29 and dividends of $4.76. The current ratio is 29% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.79%. The current dividend yield is 3.15% based on a stock price of $151.29 and dividends of $4.76. The current ratio is 13% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

The 10-year median Price/Sales (Revenue) Ratio is 4.32. The current P/S Ratio is 4.64 based on Revenue estimate for 2023 of $84,752M, Revenue per Share of $32.62 and a stock price of $151.29. This ratio is 7.3% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

Results of stock price testing is that the stock price is probably reasonable. The 10 year median dividend yield test says it is reasonable and below the median and the P/S Ratio test says it is reasonable but above the median. Most of the rest of the testing says reasonable and below the median except for the P/GP Ratio. Another thing to mention is the high P/B Ratios.

When I look at analysts’ recommendations, I find Strong Buy (11), Buy (3), Hold (4), Underperform (1) and Sell (3). This is interest and seldom do I see such wide spread opinions. What bothers some analysts is the lawsuits over baby powder causing cancel.

There are lots of buy recommendations on Stock Chase, but a number of analysts are worried about the company and especially the outstanding lawsuits. Stock Chase gives this stock 5 stars out of 5. This stock is on the American Dividend Aristocrat list. David Jagielski on Motley Fool says be careful as this stock may not be as safe and you think. Matthew DiLallo on Motley Fool thinks you can buy and hold this stock for a lifetime. The company put out a Press Release on their year-end 2022 results. The company put out a Press Release on their second quarter of 2023 results.

Zacks via Yahoo Finance put out a recent report on this stock. Simply Wall Street gives this stock 4 stars out of 5. They have two warnings of profit margins (14.2%) are lower than last year (21.1%); and large one-off items impacting financial results.

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices, and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. Its web site is here Johnson and Johnson.

The last stock I wrote about was about was Cenovus Energy Inc (TSX-CVE, NYSE-CVE) ... learn more. The next stock I will write about will be Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more on Monday, November 06, 2023 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, November 1, 2023

Cenovus Energy Inc

Sound bite for Twitter and StockTwits is: Dividend Paying Resource. Results of stock price testing is that the stock price is probably reasonable. Debt Ratios are good. The Dividend Payout Ratios (DPR) are currently fine. The current dividend yield is moderate with dividend growth moderate, but past history of dividends show dividends are volatile. See my spreadsheet on Cenovus Energy Inc.

Is it a good company at a reasonable price? This is a resource stock so it would be cyclical. The stock was up to $40.21 in 2011. I generally view resource stocks as short term investments. Although I have had some for the long term, but they consist of 1% of my portfolio. Good to track resource stocks as Canada is considered a resource country. Dividends have been volatile so it would not be a great income stock. Stock price seems in the reasonable range at the moment.

I do not own this stock of Cenovus Energy Inc (TSX-CVE, NYSE-CVE). This is another stock that was talked about at the 2010 Money Show in Toronto. There were those who liked oil companies and they mentioned both Suncor Energy Inc. (TSX-SU) and Cenovus Energy Inc. (TSX-CVE). This company was split off from EnCana (TSX-ECA) in 2009. My spreadsheet reflects this split. I was also following Alberta Energy Co. (TSX-AEC) into EnCana.

When I was updating my spreadsheet, I noticed analyst expect revenue to drop this year from $66,897M in 2022 to $56,371M in 2023. Also, analysts expect EPS to drop this year from $3.20 in 2022 to $1.76 in 2023. The Revenue and EPS for the first two quarters support this. However, the company has been raising the dividend payments by some 200% in 2022, 33% in 2023. The company raising the dividends this fast implies that the future as bright.

If you had invested in this company in December 2012, for $1,031.99 you would have bought 31 shares at $33.29 per share. In December 2022, after 10 years you would have received $160.94 in dividends. The stock would be worth $814.37. Your total return would have been $975.31. This is a total return would be a total loss of 4.08% per year with 5.32% from capital loss and 1.25% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$33.29 $1,031.99 31 11 $160.94 $814.37 $975.31

The current dividend yield is moderate with dividend growth moderate, but past history of dividends show dividends are volatile. The current dividend yield is moderate (2% to 4% ranges) at 2.09%. The 5, 10 and historical dividend yields are low (below 2%) at 1.48%, 1.60% and 1.45%. The last dividend increase was in 2023 and it was for 33%. Over the past 30 years, dividends have gone up in 13 years and down in 6 years. The last decrease was in 2020, then dividends were quickly raised between 2021 and 2023. Over the past 5 years, dividends have been raised by 11.8% per year. The company’s history points to dividends being rather volatile.

The Dividend Payout Ratios (DPR) are currently fine. The DPR for 2022 for Earnings per Share (EPS) is 15% with 5 year coverage at 90%. The DPR for 2022 for Funds from Operations (FFO) is 10% with 5 year coverage at 6%. The DPR for 2022 for Cash Flow per Share (CFPS) is 6% with 5 year coverage at 7%. The DPR for 2022 for Free Cash Flow (FCF) is 12% with 5 year coverage at 12%.

Item Cur 5 Years
EPS 14.50% 90.04%
FFO 9.66% 5.60%
CFPS 6.12% 7.45%
FCF 11.65% 12.23%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2022 is good at 0.17. The Liquidity Ratio for 2022 is fine at 1.55. The Debt Ratio for 2022 is good at 1.98. The Leverage and Debt/Equity Ratios for 2022 are fine at 2.03 and 1.03 and are currently good at 1.97 and 0.97

Type Year End Ratio Curr
Lg Term R 0.17 0.17
Intang/GW 0.06 0.06
Liquidity 1.55 1.50
Liq. + CF 2.89 2.76
Debt Ratio 1.98 2.03
Leverage 2.03 1.97
D/E Ratio 1.03 0.97

The Total Return per year is shown below for years of 5 to 30 to the end of 2022 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 11.84% 19.26% 18.01% 1.25%
2012 10 -8.81% -0.92% -2.34% 1.42%
2007 15 -0.61% 0.50% -1.46% 1.96%
2002 20 4.21% 7.02% 4.08% 2.95%
1997 25 6.90% 10.80% 7.24% 3.56%
1992 30 6.19% 11.36% 7.91% 3.45%

The Total Return per year is shown below for years of 5 to 17 to the end of 2022 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2017 5 10.14% 17.50% 16.28% 1.22%
2012 10 -11.56% -4.08% -5.32% 1.25%
2007 15 -2.68% -1.62% -3.51% 1.88%
2005 17 5.02% 1.73% -0.72% 2.45%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 5.09, 6.76 and 7.87. The corresponding 10 year ratios are 5.36, 7.07 and 8.77. The corresponding historical ratios are 12.81, 15.02 and 16.98. The current P/E Ratio is 11.03 based on a stock price of $26.80 and EPS estimate of $2.43. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive. Ratios are low because of negative ratios. A P/E Ratio of 11.03 is not a high ratio.

I also have Funds from Operations (FFO) data. The 5-year low, median, and high median Price/ Funds from Operations per Share Ratios are 4.49, 5.93 and 7.11. The corresponding 10 year ratios are 4.72, 6.22 and 7.65. The current P/FFO Ratio is 12.13 based FFO for the last 12 months of $2.2 and a stock price of $26.80. The current ratio is above the high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I get a Graham Price of $27.95. The 10-year low, median, and high median Price/Graham Price Ratios are 0.51, 0.80 and 1.23. The current P/GP Ratio is 0.96 based on a stock price of $26.80. The current ratio is between the median and high ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 1.17. The current P/B Ratio is 1.88 based on a Book Value of $27,279M, Book Value of $14.29 and a stock price of 26.80. The current ratio is 59.8% above the 1`0 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have Book Value per Share (BVPS) estimate for 2023 of $15.40. This implies a Book Value of $2,9402M and ratio of 1.74 with a stock price of $26.80. This ratio of 48% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 6.29. The current P/CF Ratio is 5.47 based on a stock price of $26.80, Cash Flow per Share estimate for 2023 of $4.90 and Cash Flow of $9,355M. The current ratio is 13% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 1.45%. The current dividend yield is 2.09% based on dividends of $0.56 and a stock price of $26.80. The current dividend yield is 44% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 1.60%. The current dividend yield is 2.09% based on dividends of $0.56 and a stock price of $26.80. The current dividend yield is 31% above the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 0.89. The current P/S Ratio is 0.91 based on Revenue estimate for 2023 of $56,371M. The current ratio is 2% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

Results of stock price testing is that the stock price is probably reasonable. The dividend yield testing says that the stock price is relatively cheap. However, the P/S Ratio test does not confirm this and says the stock price is reasonable. The rest of the testing goes from reasonable to expensive.

When I look at analysts’ recommendations, I find Strong Buy (8), Buy (10) and Hold (1). The consensus would be a strong buy. The 12 months stock price consensus is $32.79, with a high of $37.00 and low of $26.50. The 12 months consensus price of $32.79 implies a total return of 24.44% with 22.35% from capital gains and 2.09% from dividends.

Some analysts on Stock Chase like this stock, but one prefers CNQ. Stock Chase gives this stock 5 stars out of 5. It is not on any dividend list I follow. Robin Brown on Motley Fool thinks this is a place for growth in 2024. Christopher Liew on Motley Fool says this stock is a buy. The company put out a Press Release on their 2022 results. The company put out a Press Release on their second quarter of 2023 results. Zacks put out a report via Yahoo Finance about this stock.

Simply Wall Street put out a report on Yahoo Finance about who owns this company. Simply Wall Street gives this stock 3 and one half stars out of 5. They have one warning of unstable dividend track record.

Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Its web site is here Cenovus Energy Inc.

The last stock I wrote about was about was Keyera Corp (TSX-KEY, OTC-KEYUF) ... learn more. The next stock I will write about will be Johnson and Johnson (NYSE-JNJ) ... learn more on Saturday, November 04, 2023 around befor 10 am. Tomorrow on my other blog I will write about Something to Buy November 2023 learn more on Thursday, November 02, 2023 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.